In patients with acute myocardial infarction who underwent percutaneous coronary intervention, use of the Cilotax stent was associated with higher rates of target lesion revascularization, target vessel revascularization, and stent thrombosis than were everolimus-eluting stents. Use of the Cilotax dual drugeluting stent should be avoided in the treatment of myocardial infarction.
Keyphrases
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- acute coronary syndrome
- st elevation myocardial infarction
- antiplatelet therapy
- coronary artery disease
- left ventricular
- heart failure
- coronary artery bypass
- atrial fibrillation
- combination therapy